tiprankstipranks
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market
Holding KROS?
Track your performance easily

Keros Therapeutics (KROS) Income Statement

231 Followers

Keros Therapeutics Income Statement

Last quarter (Q3 2024), Keros Therapeutics's total revenue was $388.00K, an increase of 4750.00% from the same quarter last year. In Q3, Keros Therapeutics's net income was $-52.96M. See Keros Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 651.00K$ 151.00K-$ 20.10M-$ 10.00M
Cost of Revenue
------
Gross Profit
$ 651.00K$ 151.00K-$ 20.10M--
Operating Expense
$ 202.28M$ 167.69M$ 107.71M$ 76.47M$ 46.66M$ 20.56M
Operating Income
$ -204.03M$ -169.94M$ -114.79M$ -56.37M$ -46.66M$ -10.56M
Net Non Operating Interest Income Expense
--$ -1.00K$ -4.00K$ -6.00K$ -8.00K
Other Income Expense
$ 26.01M$ 14.55M$ 3.03M$ 356.00K$ -1.17M$ -1.76M
Pretax Income
$ -181.57M$ -152.99M$ -104.68M$ -56.73M$ -45.53M$ -12.34M
Tax Provision
---$ 2.01M$ -172.00K$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -181.57M$ -152.99M$ -104.68M$ -58.74M$ -45.36M$ -14.14M
Basic EPS
$ -5.21$ -5.20$ -4.15$ -2.52$ -2.93$ -1.39
Diluted EPS
$ -5.21$ -5.20$ -4.15$ -2.52$ -2.93$ -1.39
Basic Average Shares
$ 139.53M$ 29.45M$ 25.24M$ 23.33M$ 15.51M$ 8.88M
Diluted Average Shares
$ 139.53M$ 29.45M$ 25.24M$ 23.33M$ 15.51M$ 8.88M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 113.89M$ 167.69M$ 107.71M$ 76.47M$ 46.66M$ 20.56M
Net Income From Continuing And Discontinued Operation
$ -181.57M$ -152.99M$ -104.68M$ -58.74M$ -45.36M$ -12.34M
Normalized Income
$ -156.89M----$ -12.34M
Interest Expense
-----$ 8.00K
EBIT
$ -141.33M$ -152.99M$ -104.68M$ -56.73M$ -45.53M$ -12.33M
EBITDA
$ -139.18M$ -152.18M$ -104.00M$ -56.35M$ -45.25M$ -12.12M
Currency in USD

Keros Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis